Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study

Kote-Jarai, Zsofia, Olama, Ali Amin Al, Giles, Graham G, Severi, Gianluca, Schleutker, Johanna, Weischer, Maren, Campa, Daniele, Riboli, Elio, Key, Tim, Gronberg, Henrik, Hunter, David J, Kraft, Peter, Thun, Michael J, Ingles, Sue, Chanock, Stephen, Albanes, Demetrius, Hayes, Richard B, Neal, David E, Hamdy, Freddie C, Donovan, Jenny L, Pharoah, Paul, Schumacher, Fredrick, Henderson, Brian E, Stanford, Janet L, Ostrander, Elaine A, Sorensen, Karina Dalsgaard, Dörk, Thilo, Andriole, Gerald, Dickinson, Joanne L, Cybulski, Cezary, Lubinski, Jan, Spurdle, Amanda, Clements, Judith A, Chambers, Suzanne, Aitken, Joanne, Gardiner, R A Frank, Thibodeau, Stephen N, Schaid, Dan, John, Esther M, Maier, Christiane, Vogel, Walther, Cooney, Kathleen A, Park, Jong Y, Cannon-Albright, Lisa, Brenner, Hermann, Habuchi, Tomonori, Zhang, Hong-Wei, Lu, Yong-Jie, Kaneva, Radka and Cooper, Colin S ORCID: https://orcid.org/0000-0003-2013-8042 and UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology (2011) Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nature Genetics, 43 (8). pp. 785-91. ISSN 1061-4036

Full text not available from this repository. (Request a copy)

Abstract

Prostate cancer (PrCa) is the most frequently diagnosed male cancer in developed countries. We conducted a multi-stage genome-wide association study for PrCa and previously reported the results of the first two stages, which identified 16 PrCa susceptibility loci. We report here the results of stage 3, in which we evaluated 1,536 SNPs in 4,574 individuals with prostate cancer (cases) and 4,164 controls. We followed up ten new association signals through genotyping in 51,311 samples in 30 studies from the Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome (PRACTICAL) consortium. In addition to replicating previously reported loci, we identified seven new prostate cancer susceptibility loci on chromosomes 2p11, 3q23, 3q26, 5p12, 6p21, 12q13 and Xq12 (P = 4.0 × 10(-8) to P = 2.7 × 10(-24)). We also identified a SNP in TERT more strongly associated with PrCa than that previously reported. More than 40 PrCa susceptibility loci, explaining ∼25% of the familial risk in this disease, have now been identified.

Item Type:	Article
Uncontrolled Keywords:	adult,aged,aged, 80 and over,case-control studies,chromosomes, human,cohort studies,disease susceptibility,genome, human,genome-wide association study,genotype,humans,male,middle aged,polymorphism, single nucleotide,prostatic neoplasms,randomized controlled trials as topic,telomerase,sdg 3 - good health and well-being ,/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups:	Faculty of Medicine and Health Sciences > Research Groups > Cancer Studies
Depositing User:	Pure Connector
Date Deposited:	20 Jan 2014 15:58
Last Modified:	03 Nov 2022 15:34
URI:	https://ueaeprints.uea.ac.uk/id/eprint/46126
DOI:	10.1038/ng.882

Actions (login required)

View Item